Cargando…
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma
Background. Leiomyosarcomas (LMS) represent a heterogeneous subset of soft tissue sarcomas. Factors influencing prognosis for patients with metastatic extrauterine LMS (euLMS) are not well described. Limited data are available regarding responses to systemic therapy. Methods. We collected clinical a...
Autores principales: | Shoushtari, A. N., Landa, J., Kuk, D., Sanchez, A., Lala, B., Schmidt, N., Okoli, C., Chi, P., Dickson, M. A., Gounder, M. M., Keohan, M. L., Crago, A. M., Tap, W. D., D'Angelo, S. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903146/ https://www.ncbi.nlm.nih.gov/pubmed/27313489 http://dx.doi.org/10.1155/2016/3547497 |
Ejemplares similares
-
Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma
por: Imura, Yoshinori, et al.
Publicado: (2022) -
High-risk features in radiation-associated breast angiosarcomas
por: D'Angelo, S P, et al.
Publicado: (2013) -
Phase II Study of Temozolomide and Thalidomide in
Patients with Unresectable or Metastatic Leiomyosarcoma
por: Boyar, Michelle S., et al.
Publicado: (2008) -
An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
por: Bell, Sarah G., et al.
Publicado: (2021) -
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma
por: Dickson, Mark A., et al.
Publicado: (2015)